The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of two gene-expression risk scores in a large colon cancer cohort and contribution to an improved prognostic method.
Arnaud Roth
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Antonio Fabio Di Narzo
No relevant relationships to disclose
Sabine Tejpar
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Fred Bosman
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Vlad Calin Popovici
No relevant relationships to disclose
Pratyaksha Wirapati
No relevant relationships to disclose
Tao Xie
Employment or Leadership Position - Pfizer
Heather Estrella
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Adam Pavlicek
Employment or Leadership Position - Pfizer
Mao Mao
Employment or Leadership Position - Pfizer
Stock Ownership - Merck
Eric Martin
Employment or Leadership Position - Pfizer
Scott Weinrich
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
John Graeme Hodgson
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Research Funding - Pfizer
Eric Van Cutsem
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Mauro Delorenzi
No relevant relationships to disclose